These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19137175)

  • 1. A lysine walk to high relaxivity collagen-targeted MRI contrast agents.
    Caravan P; Das B; Deng Q; Dumas S; Jacques V; Koerner SK; Kolodziej A; Looby RJ; Sun WC; Zhang Z
    Chem Commun (Camb); 2009 Jan; (4):430-2. PubMed ID: 19137175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis, characterization and relaxivity of dimeric DTPA-gadonium (III) complexes with long chain alkyl esters of L-lysine].
    Yu KC; Liu LY; Wan FX; Zhou JL; Ding SW; Ye CH
    Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Apr; 26(4):670-3. PubMed ID: 16836136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.
    Port M; Idée JM; Medina C; Robic C; Sabatou M; Corot C
    Biometals; 2008 Aug; 21(4):469-90. PubMed ID: 18344005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilocus binding increases the relaxivity of protein-bound MRI contrast agents.
    Zhang Z; Greenfield MT; Spiller M; McMurry TJ; Lauffer RB; Caravan P
    Angew Chem Int Ed Engl; 2005 Oct; 44(41):6766-9. PubMed ID: 16173108
    [No Abstract]   [Full Text] [Related]  

  • 5. Probing the interaction of the biotin-avidin complex with the relaxivity of biotinylated Gd-DTPA.
    Langereis S; Kooistra HA; van Genderen MH; Meijer EW
    Org Biomol Chem; 2004 May; 2(9):1271-3. PubMed ID: 15105914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DTPA-bisamide-based MR sensor agents for peroxidase imaging.
    Querol M; Chen JW; Weissleder R; Bogdanov A
    Org Lett; 2005 Apr; 7(9):1719-22. PubMed ID: 15844889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of a bimodal target-specific contrast agent for angiogenesis.
    Dirksen A; Langereis S; de Waal BF; van Genderen MH; Meijer EW; de Lussanet QG; Hackeng TM
    Org Lett; 2004 Dec; 6(26):4857-60. PubMed ID: 15606084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gd-complexes of DTPA-bis(amide) conjugates of tranexamic acid and its esters with high relaxivity and stability for magnetic resonance imaging.
    Dutta S; Park JA; Jung JC; Chang Y; Kim TJ
    Dalton Trans; 2008 Apr; (16):2199-206. PubMed ID: 18398546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of lanthanide-grafted inorganic nanoparticles as effective contrast agents for cellular uptake imaging.
    Voisin P; Ribot EJ; Miraux S; Bouzier-Sore AK; Lahitte JF; Bouchaud V; Mornet S; Thiaudière E; Franconi JM; Raison L; Labrugère C; Delville MH
    Bioconjug Chem; 2007; 18(4):1053-63. PubMed ID: 17511491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast agents for magnetic resonance imaging synthesized with ring-opening metathesis polymerization.
    Allen MJ; Raines RT; Kiessling LL
    J Am Chem Soc; 2006 May; 128(20):6534-5. PubMed ID: 16704234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide optimization and conjugation strategies in the development of molecularly targeted magnetic resonance imaging contrast agents.
    Kolodziej AF; Zhang Z; Overoye-Chan K; Jacques V; Caravan P
    Methods Mol Biol; 2014; 1088():185-211. PubMed ID: 24146405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
    Werner EJ; Datta A; Jocher CJ; Raymond KN
    Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of two 3,5-disubstituted sulfonamide catechol ligands and evaluation of their iron(III) complexes for use as MRI contrast agents.
    Schwert DD; Richardson N; Ji G; Radüchel B; Ebert W; Heffner PE; Keck R; Davies JA
    J Med Chem; 2005 Nov; 48(23):7482-5. PubMed ID: 16279808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
    Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
    Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold nanoparticles functionalized with gadolinium chelates as high-relaxivity MRI contrast agents.
    Moriggi L; Cannizzo C; Dumas E; Mayer CR; Ulianov A; Helm L
    J Am Chem Soc; 2009 Aug; 131(31):10828-9. PubMed ID: 19722661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A paramagnetic contrast agent for detecting tyrosinase activity.
    Querol M; Bennett DG; Sotak C; Kang HW; Bogdanov A
    Chembiochem; 2007 Sep; 8(14):1637-41. PubMed ID: 17694521
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative structure-property relationship (correlation analysis) of phosphonic acid-based chelates in design of MRI contrast agent.
    Tiwari AK; Ojha H; Kaul A; Dutta A; Srivastava P; Shukla G; Srivastava R; Mishra AK
    Chem Biol Drug Des; 2009 Jul; 74(1):87-91. PubMed ID: 19519748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
    Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P
    Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents.
    Datta A; Hooker JM; Botta M; Francis MB; Aime S; Raymond KN
    J Am Chem Soc; 2008 Feb; 130(8):2546-52. PubMed ID: 18247608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.